MORGAN STANLEY - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 80 filers reported holding CTI BIOPHARMA CORP in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q4 2016$36,000
-2.7%
91,228
-8.2%
0.00%
Q3 2016$37,000
+117.6%
99,378
+96.5%
0.00%
Q2 2016$17,000
-51.4%
50,574
-23.6%
0.00%
Q1 2016$35,000
-28.6%
66,155
+65.1%
0.00%
Q4 2015$49,000
-44.3%
40,077
-33.0%
0.00%
Q3 2015$88,000
-29.6%
59,806
-6.7%
0.00%
Q2 2015$125,000
-1.6%
64,134
-9.0%
0.00%
Q1 2015$127,000
-24.9%
70,472
-2.0%
0.00%
Q4 2014$169,000
+47.0%
71,915
+51.7%
0.00%
Q3 2014$115,000
-46.3%
47,400
-37.8%
0.00%
Q2 2014$214,00076,1750.00%
Other shareholders
CTI BIOPHARMA CORP shareholders Q1 2016
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,425,000$3,363,0002.66%
ACUTA CAPITAL PARTNERS, LLC 1,228,111$2,898,0001.96%
Sio Capital Management, LLC 505,000$1,192,0000.94%
RA Capital Management 2,500,000$5,900,0000.63%
SPHERA FUNDS MANAGEMENT LTD. 750,000$1,770,0000.30%
TFS CAPITAL LLC 1,295,744$3,058,0000.29%
EAGLE ASSET MANAGEMENT INC 12,713,051$30,002,0000.17%
JW Asset Management, LLC 52,271$123,0000.09%
Lombard Odier Asset Management (USA) Corp 501,444$1,183,0000.08%
First Heartland Consultants, Inc. 74,624$176,0000.07%
View complete list of CTI BIOPHARMA CORP shareholders